Carboplatin added to sequential taxane-anthracycline in triple-negative breast cancer
Addition of carboplatin to sequential taxane-anthracycline neoadjuvant therapy increased overall survival in premenopausal women with triple-negative breast cancer
Day: February 18, 2026